Device Trial Radar · NCT07004400
A Blinded Randomized Clinical Study of RefluxStop™ Compared With Nissen Fundoplication in the Treatment of GERD
Last checked: Nov 19, 2026Latest source record: Jun 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Aug 1, 2025
Primary completion
Dec 1, 2026
Study completion Dec 1, 2026
Sponsor
- Lead sponsor
- Implantica CE Reflux Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 4, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate if the RefluxStop™ device will treat your acid reflux and improve your symptoms and how it compares to the standard surgical treatment for GERD, the Nissen fundoplication.
Conditions
- GERD (Gastroesophageal Reflux Disease)
Interventions
RefluxStop™ implantationDevice
Standard surgical technique for implantation RefluxStop™, as described in the Instructions for Use
Nissen fundoplicationProcedure
Standard surgical technique for Nissen fundoplication
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patient Reported Outcomes - Side effects (PROS) evaluationTime frame: 6 months
Locations
4 sites in 3 countries. Site status is shown where the registry gives one.
Universitätsklinik für Allgemeinchirurgie Klinische Abteilung für Viszeralchirurgie
Vienna, Austria
St. Elisabethen Krankenhaus Frankfurt
Frankfurt, Germany
Klinikum Friedrichshafen GmbH
Friedrichshafen, Germany
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.